메뉴 건너뛰기




Volumn 14, Issue 5 SUPPL., 2011, Pages

Cost-effectiveness of cardioverter defibrillators in patients with risk factors for sudden death in Argentina;Costo-Efectividad del Cardiodesfibrilador Implantable en Pacientes con Factores de Riesgo de Muerte Súbita en Argentina

Author keywords

cardioverter defibrillator; cost effectiveness; cost utility; health care utilization; sudden death

Indexed keywords

ARGENTINA; ARTICLE; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DEFIBRILLATOR; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RISK FACTOR; SOCIAL SECURITY; SUDDEN DEATH; SURVIVAL; SYSTEMATIC REVIEW; CARDIOVERSION; CONFERENCE PAPER; HEALTH CARE COST; HEALTH CARE UTILIZATION; PROPHYLAXIS; SECONDARY PREVENTION; STATISTICAL MODEL;

EID: 80052637655     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.05.030     Document Type: Article
Times cited : (10)

References (21)
  • 4
    • 25844509466 scopus 로고    scopus 로고
    • Cost-effectiveness of implantable cardioverter-defibrillators
    • DOI 10.1056/NEJMsa051989
    • G. Sanders, M. Hlatky, and D. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480 (Pubitemid 41400921)
    • (2005) New England Journal of Medicine , vol.353 , Issue.14 , pp. 1471-1480
    • Sanders, G.D.1    Hlatky, M.A.2    Owens, D.K.3
  • 5
    • 0034005813 scopus 로고    scopus 로고
    • Economic outcomes of implantable cardioverter-defibrillators
    • M. Stanton, and G. Bell Economic outcomes of implantable cardioverter-defibrillators Circulation 101 2000 1067 1074 (Pubitemid 30131711)
    • (2000) Circulation , vol.101 , Issue.9 , pp. 1067-1074
    • Stanton, M.S.1    Bell, G.K.2
  • 6
    • 33749663442 scopus 로고    scopus 로고
    • A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context
    • M. Buxton, N. Caine, and D. Chase A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context Health Technol Assess 10 2006 1 164
    • (2006) Health Technol Assess , vol.10 , pp. 1-164
    • Buxton, M.1    Caine, N.2    Chase, D.3
  • 7
    • 27544459565 scopus 로고    scopus 로고
    • The clinical and cost-effectiveness of implantable cardioverter defibrillators: A systematic review
    • J. Bryant, H. Brodin, and E. Loveman The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review Health Technol Assess 9 2005 1 150
    • (2005) Health Technol Assess , vol.9 , pp. 1-150
    • Bryant, J.1    Brodin, H.2    Loveman, E.3
  • 8
    • 25844509466 scopus 로고    scopus 로고
    • Cost-effectiveness of implantable cardioverter-defibrillators
    • DOI 10.1056/NEJMsa051989
    • G. Sanders, M. Hlatky, and D. Owens Cost-effectiveness of implantable cardioverter-defibrillators N Engl J Med 353 2005 1471 1480 (Pubitemid 41400921)
    • (2005) New England Journal of Medicine , vol.353 , Issue.14 , pp. 1471-1480
    • Sanders, G.D.1    Hlatky, M.A.2    Owens, D.K.3
  • 9
    • 70449369368 scopus 로고    scopus 로고
    • Barriers to Generalizzability of Health Economic Evaluations in Latin America and the Caribbean Region
    • F. Augustovski, C. Iglesias, and A. Manca Barriers to Generalizzability of Health Economic Evaluations in Latin America and the Caribbean Region Pharmacoeconomics 11 2009 919 929
    • (2009) Pharmacoeconomics , vol.11 , pp. 919-929
    • Augustovski, F.1    Iglesias, C.2    Manca, A.3
  • 10
    • 0036735207 scopus 로고    scopus 로고
    • Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death
    • P. Heidenreich, B. Keeffe, K. McDonald, and M. Hlatky Overview of randomized trials of antiarrhythmic drugs and devices for the prevention of sudden cardiac death Am Heart J 144 2002 422 430
    • (2002) Am Heart J , vol.144 , pp. 422-430
    • Heidenreich, P.1    Keeffe, B.2    McDonald, K.3    Hlatky, M.4
  • 11
    • 77949723235 scopus 로고    scopus 로고
    • International survey on willingness-to-pay (WTP) for one additional QALY gained: What is the threshold of cost effectiveness?
    • T. Shiroiwa, Y. Sung, and T. Fukuda International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ 19 2010 422 437
    • (2010) Health Econ , vol.19 , pp. 422-437
    • Shiroiwa, T.1    Sung, Y.2    Fukuda, T.3
  • 16
    • 80052630818 scopus 로고    scopus 로고
    • CEA Registry [Acceso el 4 de Abril 2010]
    • CEA Registry https://research.tufts-nemc.org/cear/overview/whatiscear. aspx [Acceso el 4 de Abril 2010]
  • 18
    • 80052610414 scopus 로고    scopus 로고
    • Manual Farmacetico Alfabeta [Acceso el 4 de Abril de 2010]
    • Manual Farmacetico Alfabeta www.alfabeta.net [Acceso el 4 de Abril de 2010]
  • 20
    • 14344256680 scopus 로고    scopus 로고
    • Probabilistic analysis of cost-effectiveness models: Statistical representation of parameter uncertainty
    • DOI 10.1111/j.1524-4733.2005.08101.x
    • A. Briggs Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty Value Health 8 2005 1 2 (Pubitemid 40293635)
    • (2005) Value in Health , vol.8 , Issue.1 , pp. 1-2
    • Briggs, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.